nach oben

Diabetologia

Erschienen in:

01.03.2004 | Article

Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus

verfasst von: Y. M. Cho, M. D. Ritchie, J. H. Moore, J. Y. Park, K.-U. Lee, H. D. Shin, H. K. Lee, K. S. Park, MD PhD

Erschienen in: Diabetologia | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Type 2 diabetes mellitus is a complex genetic disease, which results from interactions between multiple genes and environmental factors without any single factor having strong independent effects. This study was done to identify gene to gene interactions which could be associated with the risk of Type 2 diabetes.

Methods

We genotyped 23 different loci in the 15 candidate genes of Type 2 diabetes in 504 unrelated Type 2 diabetic patients and 133 non-diabetic control subjects. We analysed gene to gene interactions among 23 polymorphic loci using the multifactor-dimensionality reduction (MDR) method, which has been shown to be effective for detecting and characterising gene to gene interactions in case-control studies with relatively small samples.

Results

The MDR analysis showed a significant gene to gene interaction between the Ala55Val polymorphism in the uncoupling protein 2 gene (UCP2) and the 161C>T polymorphism in the exon 6 of peroxisome proliferator-activated receptor γ (PPARγ) gene. This interaction showed the maximum consistency and minimum prediction error among all gene to gene interaction models evaluated. Moreover, the combination of the UCP2 55 Ala/Val heterozygote and the PPARγ 161 C/C homozygote was associated with a reduced risk of Type 2 diabetes (odds ratio: 0.51, 95% CI: 0.34 to 0.77, p=0.0016).

Conclusions/interpretation

Using the MDR method, we showed a two-locus interaction between the UCP2 and PPARγ genes among 23 loci in the candidate genes of Type 2 diabetes. The determination of such genotype combinations contributing to Type 2 diabetes mellitus could provide a new tool for identifying high-risk individuals.

Elbein SC (2002) Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology 143:2012–2018CrossRefPubMed

Permutt MA, Hattersley AT (2000) Searching for type 2 diabetes genes in the post-genome era. Trends Endocrinol Metab 11:383–393CrossRefPubMed

Busch CP, Hegele RA (2001) Genetic determinants of type 2 diabetes mellitus. Clin Genet 60:243–254CrossRefPubMed

Moore JH, Williams SM (2002) New strategies for identifying gene-gene interactions in hypertension. Ann Med 34:88–95CrossRefPubMed

Ritchie MD, Hahn LW, Roodi N et al. (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138–147CrossRefPubMedPubMedCentral

Ritchie MD, Hahn LW, Moore JH (2003) Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24:150–157CrossRefPubMed

Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19:376–382CrossRefPubMed

Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRefPubMed

Horikawa Y, Oda N, Cox NJ et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163–175CrossRefPubMed

10.

Vionnet N, Hani El-H, Dupont S et al. (2000) Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67:1470–1480CrossRefPubMedPubMedCentral

11.

Hsueh WC, Mitchell BD, Schneider JL et al. (2001) Genome-wide scan of obesity in the Old Order Amish. J Clin Endocrinol Metab 86:1199–1205PubMed

12.

Prochazka M, Lillioja S, Tait JF et al (1993) Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 42:514–519CrossRefPubMed

13.

Mitchell BD, Cole SA, Comuzzie AG et al. (1999) A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor. Diabetes 48:1863–1867CrossRefPubMed

14.

Rice T, Chagnon YC, Perusse L et al. (2002) A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. Diabetes 51:848–855CrossRefPubMed

15.

Shin HD, Kim LH, Park BL et al. (2003) Polymorphisms in fatty acid-binding protein-3 (FABP3)–putative association with type 2 diabetes mellitus. Hum Mutat 22:180 (Abstract)CrossRefPubMed

16.

Urhammer SA, Hansen T, Borch-Johnsen K, Pedersen O (2000) Studies of the synergistic effect of the Trp/Arg64 polymorphism of the beta3-adrenergic receptor gene and the −3826 A→G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 young Danish subjects. J Clin Endocrinol Metab 85:3151–3154PubMed

17.

Sivenius K, Valve R, Lindi V, Niskanen L, Laakso M, Uusitupa M (2000) Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on long-term body weight change in Finnish type 2 diabetic and non-diabetic control subjects. Int J Obes Relat Metab Disord 24:514–519CrossRefPubMed

18.

Mentuccia D, Proietti-Pannunzi L, Tanner K et al. (2002) Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 51:880–883CrossRefPubMed

19.

Ishii T, Hirose H, Kawai T et al. (2001) Effects of intestinal fatty acid-binding protein gene Ala54Thr polymorphism and beta3-adrenergic receptor gene Trp64Arg polymorphism on insulin resistance and fasting plasma glucose in young to older Japanese men. Metabolism 50:1301–1307CrossRefPubMed

20.

Hsueh WC, Cole SA, Shuldiner AR et al. (2001) Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity. Diabetes Care 24:672–677CrossRefPubMed

21.

Cox NJ, Frigge M, Nicolae DL et al. (1999) Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 21:213–215CrossRefPubMed

22.

Dalgaard LT, Pedersen O (2001) Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia 44:946–965CrossRefPubMed

23.

Meirhaeghe A, Fajas L, Helbecque N et al. (1998) A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 7:435–440CrossRefPubMed

24.

Poulsen P, Andersen G., Fenger M et al. (2003) Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both? Diabetes 52:194–198CrossRefPubMed

25.

DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687CrossRefPubMed

26.

Moore JH (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56:73–82CrossRefPubMed

Titel: Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus
verfasst von: Y. M. Cho
M. D. Ritchie
J. H. Moore
J. Y. Park
K.-U. Lee
H. D. Shin
H. K. Lee
K. S. Park, MD PhD
Publikationsdatum: 01.03.2004
Verlag: Springer Berlin Heidelberg
Erschienen in: Diabetologia / Ausgabe 3/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-003-1321-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2004

In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes

Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state

Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots

Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner

Oscillations of membrane potential and cytosolic Ca2+ concentration in SUR1−/− beta cells